Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment
Aptevo Therapeutics (NASDAQ:APVO) announced two additional frontline Acute Myeloid Leukemia (AML) patients have achieved ...
BlackDoctor.org11d
How Chronic Myeloid Leukemia Affects Black Women Differently
Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...
How does Acute Myeloid Leukemia affect mental health and emotional well-being in patients?
The journey of fighting Acute Myeloid Leukemia (AML) in India encompasses severe physical and emotional challenges for both ...
Us Weekly3d
Jon Batiste Shares Update on Wife Suleika Jaouad’s Cancer Treatment Following Third Leukemia Diagnosis
Jon Batiste shared a positive update on his wife Suleika Jaouad's health following her September 2024 announcement that she'd ...
Pacylex Pharmaceuticals Announces the First Acute Myeloid Leukemia (AML) Patient Dosed with Zelenirstat In a New Phase 1/2 Clinical Trial
Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing ...
Science Daily7d
Leukemia News
Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...
Q&A: Novel immunotherapy is poised to tackle multiple cancers
CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen ...
Pulmonology Advisor1d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in Type 2 Diabetes
GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.